ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 85 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2022. The put-call ratio across all filers is 5.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $49,702 | -64.2% | 70,400 | -23.2% | 0.00% | – |
| Q3 2022 | $139,000 | +59.8% | 91,700 | +5.0% | 0.00% | – |
| Q2 2022 | $87,000 | -86.7% | 87,300 | -80.7% | 0.00% | -100.0% |
| Q1 2022 | $652,000 | -65.7% | 452,600 | +24.1% | 0.00% | -60.0% |
| Q4 2021 | $1,903,000 | +500.3% | 364,600 | +570.2% | 0.01% | +400.0% |
| Q3 2021 | $317,000 | -61.5% | 54,400 | -46.8% | 0.00% | -50.0% |
| Q2 2021 | $824,000 | -25.8% | 102,200 | -23.4% | 0.00% | -33.3% |
| Q1 2021 | $1,111,000 | +20.5% | 133,500 | +9.8% | 0.00% | +50.0% |
| Q4 2020 | $922,000 | +224.6% | 121,600 | +357.1% | 0.00% | +100.0% |
| Q3 2020 | $284,000 | -81.4% | 26,600 | -73.5% | 0.00% | -75.0% |
| Q2 2020 | $1,524,000 | +254.4% | 100,500 | +94.8% | 0.00% | +100.0% |
| Q1 2020 | $430,000 | +56.4% | 51,600 | +216.6% | 0.00% | +100.0% |
| Q4 2019 | $275,000 | – | 16,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,193,795 | $33,258,000 | 20.10% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,068,942 | $61,685,000 | 7.83% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,394,052 | $21,134,000 | 3.38% |
| Selkirk Management LLC | 348,805 | $5,288,000 | 2.27% |
| Trellus Management Company, LLC | 50,000 | $758,000 | 0.82% |
| Cannell & Co. | 1,118,439 | $16,956,000 | 0.67% |
| Chicago Capital, LLC | 755,483 | $11,453,000 | 0.66% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $2,350,000 | 0.55% |
| Belpointe Asset Management LLC | 209,708 | $3,179,000 | 0.41% |
| TCI Wealth Advisors, Inc. | 55,586 | $843,000 | 0.36% |